NuCana (NCNA) Depreciation & Amortization (CF) (2017 - 2025)

NuCana (NCNA) reported Depreciation & Amortization (CF) of $91781.5 for Q4 2025, down 37.82% on a YoY basis from $147602.7 in Q4 2024, and down 1.42% sequentially from $93106.0 in Q3 2025.

NuCana (NCNA) Depreciation & Amortization (CF) (2017 - 2025) Analysis & Trends

NuCana (NCNA) has 9 years of Depreciation & Amortization (CF) data on file, last reported at $91781.5 in Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 37.82% year-over-year to $91781.5; the trailing twelve-month figure through Dec 2025 stood at $184887.5 (down 72.29% YoY), and the FY2025 full-year result was $361271.8, down 45.86% from the prior year.
  • Depreciation & Amortization (CF) eased to $91781.5 in Q4 2025, from $93106.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $362614.9 in Q4 2021 to a low of $91781.5 in Q4 2025.
  • A 5-year average of $216883.8 and a median of $178426.6 in 2023 frame the typical range for Depreciation & Amortization (CF).
  • Across the five-year window, Depreciation & Amortization (CF) advanced 23.15% in 2021 and slumped 47.22% in 2023, its largest moves.
  • Tracing NCNA's Depreciation & Amortization (CF) over 5 years: stood at $362614.9 in 2021, then retreated by 5.19% to $343792.8 in 2022, then tumbled by 49.1% to $175002.4 in 2023, then fell by 15.66% to $147602.7 in 2024, then sank by 37.82% to $91781.5 in 2025.
  • Business Quant data shows NCNA's Depreciation & Amortization (CF) at $91781.5 in Q4 2025, $93106.0 in Q3 2025, and $147602.7 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 41.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - 91,781.47
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 91,781.47
Dec 31, 2025 91,781.47
Sep 30, 2025 93,105.99
Sep 30, 2025 93,105.99
Dec 31, 2024 147,602.71
Dec 31, 2024 147,602.71
Sep 30, 2024 175,405.52
Sep 30, 2024 175,405.52
Jun 30, 2024 171,662.02
Jun 30, 2024 171,662.02
Mar 31, 2024 172,518.47
Mar 31, 2024 172,518.47
Dec 31, 2023 175,002.42
Dec 31, 2023 175,002.42
Sep 30, 2023 184,935.98
Sep 30, 2023 184,935.98
Jun 30, 2023 181,447.66
Jun 30, 2023 181,447.66
Mar 31, 2023 173,817.86
Mar 31, 2023 173,817.86